雪天鹽業(600929.SH):電池級純鹼項目預計於2025年6月達到可使用狀態
格隆匯4月30日丨雪天鹽業(600929.SH)在投資者互動平台表示,公司於2022年12月參股湖南美特新材料有限公司,2023年組織成立鈉電研究院,對層狀氧化物、聚陰離子化合物方向進行研究開發。截至目前,層狀氧化物路線已發佈正式產品並實現噸級銷售,聚陰離子化合物方向已向下遊開展產品送測。後續將進一步探索相關產品於儲能市場的應用。電池級純鹼項目預計於2025年6月達到可使用狀態。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.